Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Por Sheppard, John, Bergmann, Mark, Schechter, Barry A, Luchs, Jodi, Ogundele, Abayomi, Karpecki, Paul
Publicado no Clin Ophthalmol (2021)

The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK

Por Prior, Y., Tennant, A., Tyson, S., Hammond, A.
Publicado no BMC Musculoskelet Disord (2020)

Vandetanib and indwelling pleural catheter for non-small cell lung cancer with recurrent malignant pleural effusion

Por Massarelli, Erminia, Onn, Amir, Marom, Edith M., Alden, Christine M., Liu, Diane D., Tran, Hai T., Mino, Barbara, Wistuba, Ignacio I., Faiz, Saadia A., Bashoura, Lara, Eapen, George A., Morice, Rodolfo C., Jack Lee, J., Hong, Waun K., Herbst, Roy S., Jimenez, Carlos A.
Publicado em 2014

Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority randomized controlled trial

Por van der Houwen, L E E, Lier, M C I, Schreurs, A M F, van Wely, M, Hompes, P G A, Cantineau, A E P, Schats, R, Lambalk, C B, Mijatovic, V
Publicado no Hum Reprod Open (2019)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study

Por Hong, C‐H., Papp, K.A., Lophaven, K.W., Skallerup, P., Philipp, S.
Publicado no J Eur Acad Dermatol Venereol (2017)

Growth performance and nutrient digestibility of growing and finishing pigs fed multienzyme-supplemented low-energy and -amino acid diets

Por Jerez-Bogota, Kevin, Sánchez, Cristian, Ibagon, Jimena, Jlali, Maamer, Cozannet, Pierre, Preynat, Aurélie, Woyengo, Tofuko A
Publicado no Transl Anim Sci (2020)

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies

Por Kunos, Charles A., Brindle, James, Waggoner, Steven, Zanotti, Kristine, Resnick, Kimberly, Fusco, Nancy, Adams, Ramon, Debernardo, Robert
Publicado em 2012

SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2

Por Hesketh, Paul J., Chansky, Kari, Wozniak, Antoinette J., Hirsch, Fred R., Spreafico, Anna, Moon, James, Mack, Philip C., Marchello, Benjamin T., Franklin, Wilbur A., Crowley, John J., Gandara, David R.
Publicado em 2008

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.

Por Pyrhönen, S., Valavaara, R., Modig, H., Pawlicki, M., Pienkowski, T., Gundersen, S., Bauer, J., Westman, G., Lundgren, S., Blanco, G., Mella, O., Nilsson, I., Hietanen, T., Hindy, I., Vuorinen, J., Hajba, A.
Publicado em 1997

A Phase III Randomized, Double Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: NCCTG study N04CA

Por Loprinzi, Charles L., Balcueva, Ernie P., Liu, Heshan, Sloan, Jeff A., Kottschade, Lisa A., Stella, Philip J., Carlson, Mark D., Moore, Dennis F., Zon, Robin T., Levitt, Ralph, Jaslowski, Anthony J.
Publicado em 2011

The impact of “super-dosing” phytase in pig diets on growth performance during the nursery and grow-out periods()

Por Holloway, Cassie L, Boyd, R Dean, Koehler, Dean, Gould, Stacie A, Li, Qingyun, Patience, John F
Publicado no Transl Anim Sci (2018)

Thymidylate Synthase (TYMS) Enhancer Region Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd Line Treatment of Advanced Pancreatic Cancer

Por Weekes, Colin D., Nallapareddy, Sujatha, Rudek, Michelle A., Norris-Kirby, Alexis, Laheru, Daniel, Jimeno, Antonio, Donehower, Ross C., Murphy, Kathleen M., Hidalgo, Manuel, Baker, Sharyn D., Messersmith, Wells A.
Publicado em 2010

Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial

Por Verschuur, Arnauld C., Bajčiová, Viera, Mascarenhas, Leo, Khosravan, Reza, Lin, Xun, Ingrosso, Antonella, Janeway, Katherine A.
Publicado no Cancer Chemother Pharmacol (2019)

Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer

Por Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko
Publicado em 2020-02-01

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Por Robison, Nathan J, Campigotto, Federico, Chi, Susan N, Manley, Peter E, Turner, Christopher D, Zimmerman, Mary Ann, Chordas, Christine A, Werger, Annette M, Allen, Jeffrey C, Goldman, Stewart, Rubin, Joshua B, Isakoff, Michael S, Pan, Wilbur J, Khatib, Ziad A, Comito, Melanie A, Bendel, Anne E, Pietrantonio, Jay B, Kondrat, Laura, Hubbs, Shannon M, Neuberg, Donna S, Kieran, Mark W
Publicado no Pediatr Blood Cancer (2014)

SUN-125 Phase Ib Study of Dual Therapy with an Aromatase Inhibitor Exemestane and Carboplatin-Based...

Por Young, Patricia A, Marquez-Garban, Diana C, Goodglick, Lee, Noor, Zorawar S, Moatamed, Neda, Elashoff, David, Grogan, Tristan, Romero, Tahmineh, Sasano, Hironobu, Saito, Ryoko, Rausch, Rebecca, Hamilton, Nalo, Dubinett, Steven M, Garon, Edward, Pietras, Richard J
Publicado no J Endocr Soc (2020)

A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer

Por McKay, Rana R., Werner, Lillian, Mostaghel, Elahe A., Lis, Rosina, Voznesensky, Olga, Zhang, Zhenwei, Marck, Brett T., Matsumoto, Alvin M., Domachevsky, Liran, Zukotynski, Katherine A., Bhasin, Manoj, Bubley, Glenn J., Montgomery, Bruce, Kantoff, Philip W., Balk, Steven P., Taplin, Mary-Ellen
Publicado no Clin Cancer Res (2016)

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory...

Por Moreno-González, G., Mussetti, A., Albasanz-Puig, A., Salvador, I., Sureda, A., Gudiol, C., Salazar, R., Marin, M., Garcia, M., Navarro, V., de la Haba Vaca, I., Coma, E., Sanz-Linares, G., Dura, X., Fontanals, S., Serrano, G., Cruz, C., Mañez, R.
Publicado no Trials (2021)

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Por Kwak, Eunice L., Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T., Solomon, Benjamin, Maki, Robert G., Ou, Sai-Hong I., Dezube, Bruce J., Jänne, Pasi A., Costa, Daniel B., Varella-Garcia, Marileila, Kim, Woo-Ho, Lynch, Thomas J., Fidias, Panos, Stubbs, Hannah, Engelman, Jeffrey A., Sequist, Lecia V., Tan, WeiWei, Gandhi, Leena, Mino-Kenudson, Mari, Wei, Greg C., Shreeve, S. Martin, Ratain, Mark J., Settleman, Jeffrey, Christensen, James G., Haber, Daniel A., Wilner, Keith, Salgia, Ravi, Shapiro, Geoffrey I., Clark, Jeffrey W., Iafrate, A. John
Publicado em 2010

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non...

Por Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Publicado no Cancer (2010)